Usefulness of the Platelet-to-Lymphocyte Ratio in Predicting Angiographic Reflow After Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction

被引:112
作者
Kurtul, Alparslan [1 ]
Yarlioglues, Mikail [1 ]
Murat, Sani Namik [1 ]
Ergun, Gokhan [1 ]
Duran, Mustafa [1 ]
Kasapkara, Haci Ahmet [2 ]
Demircelik, Muhammed Bora [3 ]
Cetin, Mustafa [4 ]
Ocek, Adil Hakan [1 ]
机构
[1] Ankara Educ & Res Hosp, Dept Cardiol, Ankara, Turkey
[2] Yildirim Beyazit Univ, Fac Med, Dept Cardiol, Ankara, Turkey
[3] Turgut Ozal Univ, Fac Med, Dept Cardiol, Ankara, Turkey
[4] Ankara Numune Training & Res Hosp, Dept Cardiol, Ankara, Turkey
关键词
NO-REFLOW; PROGNOSTIC VALUE; NEUTROPHIL/LYMPHOCYTE RATIO; ACTIVATION; IMPACT; FLOW; ANGIOPLASTY;
D O I
10.1016/j.amjcard.2014.04.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Impaired coronary flow after primary percutaneous coronary intervention (PPCI) is associated with short- and long-term morbidity and mortality in patients with acute ST-segment elevation myocardial infarction (STEMI). Recent studies have demonstrated that platelet-to-lymphocyte ratio (PLR) is associated with adverse cardiovascular outcomes. The aim of this study was to assess the relation between admission PLR and angiographic reflow after PPCI. A total of 520 patients with acute STEMI (age 60 +/- 13 years; 74% men) occurring within 12 hours of the onset of symptoms who underwent PPCI were enrolled. The PLR and other laboratory parameters were measured before PPCI. The patients were divided into 2 groups based on the postintervention Thrombolysis in Myocardial Infarction (TIMI) flow grade: normal-reflow group (defined as postintervention TIMI grade 3 flow) and none-reflow group (consisted of both patients with angiographic no-reflow defined as postintervention TIMI grades 0 to 1 flow and slow flow defined as postintervention TIMI grade 2 flow). There were 117 patients (22.5%) in the none-reflow group (age 68 +/- 13 years and 77% men) and 403 patients in the normal-reflow group (age 58 +/- 12 years and 63% men). The none-reflow group had significantly higher PLR compared with the normal-reflow group (219 79 vs 115 +/- 59, p <0.001). In logistic regression analysis, PLR (odds ratio 1.818, 95% confidence interval 1.713 to 1.980, p <0.001) and total stent length (OR 1.052, confidence interval 1.019 to 1.086, p = 0.002) were independent predictors of none-reflow after PPCI. In conclusion, preintervention PLR is a strong and independent predictor of slow flow/no-reflow after PPCI in patients with acute STEMI. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:342 / 347
页数:6
相关论文
共 30 条
[1]  
Acar G, 2013, CLIN APPL THROMB HEM
[2]   Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis [J].
Alexandrakis, MG ;
Passam, FH ;
Moschandrea, IA ;
Christophoridou, AV ;
Pappa, CA ;
Coulocheri, SA ;
Kyriakou, DS .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (02) :135-140
[3]   Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction [J].
Azab, Basem ;
Shah, Neeraj ;
Akerman, Meredith ;
McGinn, Joseph T., Jr. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (03) :326-334
[4]   The platelet lymphocyte ratio may be useful inflammatory indicator in clinical practice [J].
Balta, Sevket ;
Demirkol, Sait ;
Kucuk, Ugur .
HEMODIALYSIS INTERNATIONAL, 2013, 17 (04) :668-669
[5]   Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality [J].
Brosh, David ;
Assali, Abid R. ;
Mager, Aviv ;
Porter, Avital ;
Hasdai, David ;
Teplitsky, Igal ;
Rechavia, Eldad ;
Fuchs, Shmuel ;
Battler, Alexander ;
Kornowski, Ran .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (04) :442-445
[6]   The impact of admission C-reactive protein levels on the development of no-reflow phenomenon after primary PCI in patients with acute myocardial infarction: The role of inflammation [J].
Celik, Turgay ;
Iyisoy, Atila ;
Yuksel, U. Cagdas ;
Jata, Bekim ;
Ozkan, Mustafa .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 136 (01) :86-88
[7]   Effects of distal embolization on the timing of platelet and inflammatory cell activation in interventional coronary no-reflow [J].
Charron, Thierry ;
Jaffe, Ronen ;
Segev, Amit ;
Bang, K. W. Annie ;
Qiang, Beiping ;
Sparkes, John D. ;
Butany, Jagdish ;
Dick, Alexander J. ;
Freedman, John ;
Strauss, Bradley H. .
THROMBOSIS RESEARCH, 2010, 126 (01) :50-55
[8]  
Duygu H, 2008, J INVASIVE CARDIOL, V20, P120
[9]   Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease Patients [J].
Gary, Thomas ;
Pichler, Martin ;
Belaj, Klara ;
Hafner, Franz ;
Gerger, Armin ;
Froehlich, Harald ;
Eller, Philipp ;
Rief, Peter ;
Hackl, Gerald ;
Pilger, Ernst ;
Brodmann, Marianne .
PLOS ONE, 2013, 8 (07)
[10]   Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration The Comparison of Intracoronary Versus Intravenous Abciximab Administration During Emergency Reperfusion of ST-Segment Elevation Myocardial Infarction (CICERO) Trial [J].
Gu, Youlan L. ;
Kampinga, Marthe A. ;
Wieringa, Wouter G. ;
Fokkema, Marieke L. ;
Nijsten, Maarten W. ;
Hillege, Hans L. ;
van den Heuvel, Ad F. M. ;
Tan, Eng-Shiong ;
Pundziute, Gabija ;
van der Werf, Rik ;
Guyomi, Siyrous Hoseyni ;
van der Horst, Iwan C. C. ;
Zijlstra, Felix ;
de Smet, Bart J. G. L. .
CIRCULATION, 2010, 122 (25) :2709-2717